CorVista System with PH Add-On vs Eko Foundation Analysis Software with Transformers (EFAST)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

The CorVista System with PH Add-On offers a non-invasive, point-of-care diagnostic platform for rapid assessment of coronary artery disease and pulmonary hypertension by analyzing cardiac and hemodynamic signals. In contrast, EFAST by Eko Health enhances routine physical exams by providing real-time AI-powered detection of structural murmurs and atrial fibrillation during auscultation with digital stethoscopes. While both are FDA-cleared cardiology AI tools, CorVista provides a broader diagnostic assessment for specific conditions, whereas EFAST augments the traditional stethoscope exam for immediate insights into murmurs and AFib.

Choose CorVista System with PH Add-On if…

Choose the CorVista System with PH Add-On if you require a rapid, non-invasive, point-of-care diagnostic solution for the assessment of coronary artery disease and pulmonary hypertension. This system is ideal for situations where quick insights into these specific cardiovascular conditions are needed without the use of radiation, contrast agents, or extensive patient preparation.

View CorVista System with PH Add-On →

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose Eko Foundation Analysis Software with Transformers (EFAST) if you aim to enhance routine physical examinations with real-time, AI-powered auscultation for the immediate detection of structural murmurs and atrial fibrillation. This tool is best suited for clinicians seeking to augment their digital stethoscope examinations with advanced AI insights and seamless EMR integration to improve diagnostic accuracy during standard patient encounters.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CorVista System with PH Add-On Eko Foundation Analysis Software with Transformers (EFAST)
Pricing Unknown Subscription-based, contact for details
Deployment Cloud-based, point-of-care system. Cloud-based Software as a Medical Device (SaMD)
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

While Tool A offers significant patient benefits by being non-invasive and requiring no preparation, Tool B excels in clinician usability. Its seamless integration into existing clinical workflows, such as real-time AI analysis during auscultation with Eko digital stethoscopes and EMR integration, provides immediate, actionable insights for healthcare professionals during routine exams.

Clinical Value

Eko Foundation Analysis Software with Transformers (EFAST)

Both tools are FDA-cleared and address critical cardiovascular conditions. However, Tool B provides specific, high-performance metrics for its AI-powered structural murmur detection (93% sensitivity, 91% specificity) and AFib detection (95% sensitivity, 94% specificity). Tool A's reported metrics for CAD (88% sensitivity, 51% specificity, 99% NPV) and PH (AUC-ROC 0.93, 78% sensitivity) are valuable, but Tool B's consistently higher sensitivity and specificity across its indications give it an edge in quantifiable clinical accuracy.

Pricing & Value

Eko Foundation Analysis Software with Transformers (EFAST)

Tool B offers greater transparency regarding its pricing model, indicating a subscription-based service, an approximate daily cost for its hardware, and a free trial option. In contrast, Tool A only states 'contact for pricing,' providing no public insight into its cost structure or value proposition.

Enterprise Readiness

Eko Foundation Analysis Software with Transformers (EFAST)

Both tools are cloud-based and claim HIPAA compliance with Business Associate Agreements (BAAs). However, Tool B explicitly highlights 'EMR integration for streamlined documentation,' which is a crucial feature for seamless adoption, data flow, and workflow efficiency within larger healthcare enterprises.

Innovation

CorVista System with PH Add-On

Tool A's innovation is more disruptive, pioneering a completely non-invasive, no-prep diagnostic solution for coronary artery disease and pulmonary hypertension, eliminating the need for radiation, contrast agents, injections, fasting, or exercise. While Tool B brings advanced AI to enhance traditional auscultation, Tool A represents a more significant paradigm shift in the diagnostic pathway for complex cardiovascular conditions.

Support & Docs

Eko Foundation Analysis Software with Transformers (EFAST)

Tool B clearly offers extensive and easily accessible support resources through its comprehensive 'Eko Help Center,' which includes user manuals, FAQs, how-to videos, troubleshooting guides, and direct contact options for support. Publicly available detailed support or documentation for Tool A was not readily found through web searches.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CorVista System with PH Add-On Eko Foundation Analysis Software with Transformers (EFAST)
Product Name CorVista System with PH Add-On Eko Foundation Analysis Software with Transformers (EFAST)
Company Analytics for Life Eko Health
Primary Use Case Non-invasive, point-of-care AI diagnostic platform for rapid assessment of coronary artery disease and pulmonary hypertension. Advanced AI model assisting clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation.
Key Diagnostic Capabilities Coronary artery disease (CAD), Pulmonary Hypertension (PH) Structural murmurs associated with heart disease, Atrial Fibrillation (AFib)
Core Technology / Modality Non-invasive, machine-learned algorithms analyzing cardiac and hemodynamic signals; No radiation, contrast agents, injections, fasting, or exercise required. AI-powered analysis during auscultation; Integrates with Eko digital stethoscopes; Enhanced audio with noise cancellation and amplification.

Videos

Demos, reviews, and walkthroughs featuring CorVista System with PH Add-On and Eko Foundation Analysis Software with Transformers (EFAST).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The CorVista System with PH Add-On is designed for the rapid assessment of coronary artery disease (CAD) and pulmonary hypertension (PH) using machine-learned algorithms. EFAST by Eko Health assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation (AFib) in real-time during routine exams.
The CorVista System offers a non-invasive, point-of-care test that requires no radiation, contrast agents, injections, fasting, or exercise, analyzing cardiac and hemodynamic signals. EFAST integrates with Eko digital stethoscopes, providing real-time AI analysis during auscultation, enhanced audio with noise cancellation, and waveform visualization.
EFAST provides specific performance metrics, with 93% sensitivity and 91% specificity for AI-powered structural murmur detection, and 95% sensitivity and 94% specificity for AI-powered atrial fibrillation detection. The provided information for the CorVista System with PH Add-On indicates a diagnostic performance of 82% sensitivity and 92% specificity for elevated mPAP, an indicator of pulmonary hypertension.
The CorVista System involves data collection at the point-of-care using its system, with results accessed via a secure web portal. EFAST seamlessly integrates with Eko digital stethoscopes (e.g., CORE 500) and offers EMR integration for streamlined documentation.
The CorVista System provides rapid results available within minutes of the test, accessible through a secure web portal. EFAST delivers real-time AI analysis during auscultation, providing actionable cardiac insights instantly during routine exams.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.